Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption

Prenatal Diagnosis

Volumn 27, Issue 3, 2007, Pages 240-243

  Tikkanen, Minna ^a   Hämäläinen, Esa ^a   Nuutila, Mika ^a   Paavonen, Jorma ^a   Ylikorkala, Olavi ^a   Hiilesmaa, Vilho ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Free beta human chorionic gonadotrophin; Maternal serum alpha fetoprotein; Placental abruption; Risk factor

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADULT; ARTICLE; BLEEDING TENDENCY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL ATTITUDE; PREECLAMPSIA; PRENATAL SCREENING; PRIORITY JOURNAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SOLUTIO PLACENTAE; TRISOMY 21;

ABRUPTIO PLACENTAE; ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 33947409218     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1654     Document Type: Article

References (19)

1. Ananth CV, Smulian JC, Vintzileos AM. 1999. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol 93: 622-628.
2. Ananth CV, Oyelese Y, Yeo L, Pradhan A, Vintzileos AM. 2005. Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants. Am J Obstet Gynecol 192: 191-198.
3. Chandra S, Scott H, Dodds L, Watts C, Blight C, Van den Hof M. 2003. Unexplained elevated maternal serum α-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol 189: 775-781.
4. Dugoff L, Hobbins JC, Malone FD, et al. 2005. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol 106: 260-267.
5. Eskes TK. 1997. Abruptio placentae. Eur J Obstet Gynecol Reprod Biol 75: 63-70.
6. Haddow JE, Palomaki GE. 1999. Biochemical markers of fetal disorders in maternal serum and amniotic fluid. In Medicine of the Fetus and Mother, Reece EA, Hobbins JC (eds). Lippincott-Raven Publishers: Philadelphia, PA; 689-706.
7. Huerta-Enochian G, Katz V, Erfurth S. 2001. The association of abnormal alpha-fetoprotein and adverse pregnancy outcome: does increased fetal surveillance improve fetal outcome? Am J Obstet Gynecol 184: 1549-1555.
8. Kazt VL, Chescheir NC, Cefalo RC. 1990. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv 45: 719-726.
9. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. 2004. Disorders of placental development. In Placental Pathology. Atlas of Nontumor Pathology, King DW (ed.). The American Registry of Pathology: Washington, DC; 53-54.
10. Liu DF, Dickerman LH, Redline RW. 1999. Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels. Am J Clin Pathol 111: 209-215.
11. Pihkala J, Hakala T, Voutilainen P, Raivio K. 1989. Characteristic of recent fetal growth curves in Finland. Duodecim 105: 1540-1546.
12. Purdie DW, Young JL, Guthrie KA, Picton CE. 1983. Fetal growth achievement and elevated maternal serum alpha-fetoprotein. Br J Obstet Gynaecol 90: 433-436.
13. Salafia CM, Silberman C, Herrera NE, Mahoney MJ. 1988. Placental pathology at term associated with elevated midtrimester maternal serum AFP concentration. Am J Obstet Gynecol 158: 1064-1066.
14. Smith GCS, Shah I, Crossley JA, et al. 2006. Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome. Obstet Gynecol 107: 161-166.
15. Spencer K. 1998. The influence of smoking on maternal serum AFP and free beta hCG levels and the impact on screening for Down syndrome. Prenat Diagn 81: 225-234.
16. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. 2006a. Prepregnancy risk factors for placental abruption. Acta Obstet Gynecol Scand 85: 40-44.
17. Tikkanen M, Nuutila M, Hiilesmaa V, Paavonen J, Ylikorkala O. 2006b. Clinical presentation and risk factors of placental abruption. Acta Obstet Gynecol Scand 85: 700-705.
18. Van Rijn M, Van der Schouw YT, Hagenaars AM, Visser GHA, Christiaens GCMI. 1999. Adverse obstetric outcome in low-and high- risk pregnancies: predictive value of maternal serum screening. Obstet Gynecol 94: 929-934.
19. WHO. 1992. ICD-10, International Statistical Classification of Diseases and Related Health Problems, vol. 1. West Point, Rauma, Finland, Geneva.